Therefore, we next analyzed CD99 surface protein expression on T cells from the CSF of MS patients (n = 24 females, 9 males) and of patients with non-neuroinflammatory diseases (NND patients; n = 11 females, 5 males). The gene discussed is CD99; the disease is myeloid sarcoma.